Skip to main content
. Author manuscript; available in PMC: 2017 Jul 17.
Published in final edited form as: J Biomed Nanotechnol. 2009 Aug;5(4):351–363. doi: 10.1166/jbn.2009.1044

Fig. 3.

Fig. 3

Tissue distribution study of siRNA formulated in different LPD formulations. (A) FAM-labeled siRNA was formulated into LPD formulations and i.v. injected into nude mice through tail vein. After 4 hours, tumor and major organs were collected. FAM fluorescence signals were detected by Xenogen IVIS-100 imaging system. (B) Quantitative results of FAM-siRNA tissue distribution. Data =mean ±SD, n = 3–4. NP, nanoparticles. Reproduced with permission from, [55], S. D. Li et al., Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Mol. Ther. 16, 163 (2008). © 2008.